989
Views
15
CrossRef citations to date
0
Altmetric
Award Review

Bioactive compounds in plant materials for the prevention of diabetesand obesity

ORCID Icon
Pages 975-985 | Received 18 Dec 2018, Accepted 02 Feb 2019, Published online: 17 Feb 2019

References

  • Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239–2251.
  • Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376:254–266.
  • Hameed I, Masoodi SR, Mir SA, et al. Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes. 2015;6:598–612.
  • Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell. 2012;148:1160–1171.
  • Thrasher J. Pharmacologic management of type 2 diabetes mellitus: available therapies. Am J Med. 2017;130:S4–S17.
  • MacDaniels J, Schwartz T. Effectiveness, tolerability and practical application of the newer generation anti-obesity medications. Drugs Context. 2016;5:212291.
  • Joharapurkar A, Jain M, Dhanesha N. Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity. Diabetes, Metab Syndr Obes Targets Ther. 2014;7:73.
  • Ríos J, Francini F, Schinella G. Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 2015;81:975–994.
  • Fu C, Jiang Y, Guo J, et al. Natural products with anti-obesity effects and different mechanisms of action. J Agric Food Chem. 2016;64:9571–9585.
  • de la Garza A, Milagro F, Boque N, et al. Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta Med. 2011;77:773–785.
  • Shi Y, Burn P. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov. 2004;3:695–710.
  • Kato E, Nakagomi R, Gunawan-Puteri MDPT, et al. Identification of hydroxychavicol and its dimers, the lipase inhibitors contained in the Indonesian spice, Eugenia polyantha. Food Chem. 2013;136:1239–1242.
  • Kato E, Yama M, Nakagomi R, et al. Substrate-like water soluble lipase inhibitors from Filipendula kamtschatica. Bioorg Med Chem Lett. 2012;22:6410–6412.
  • Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today. 2007;12:879–889.
  • Chen L, Tuo B, Dong H. Regulation of intestinal glucose absorption by ion channels and transporters. Nutrients. 2016;8:43.
  • Joshi SR, Standl E, Tong N, et al. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review. Expert Opin Pharmacother. 2015;16:1959–1981.
  • Tundis R, Loizzo MR, Menichini F. Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini Rev Med Chem. 2010;10:315–331.
  • Arsiningtyas IS, Gunawan-Puteri MDPT, Kato E, et al. Identification of α-glucosidase inhibitors from the leaves of Pluchea indica (L.) Less., a traditional Indonesian herb: promotion of natural product use. Nat Prod Res. 2014;28:1350–1353.
  • Noda K, Kato E, Kawabata J. Intestinal α-Glucosidase Inhibitors in Achillea millefolium. Nat Prod Commun. 2017;12:1259–1261.
  • Yin Z, Zhang W, Feng F, et al. α-Glucosidase inhibitors isolated from medicinal plants. Food Sci Hum Wellness. 2014;3:136–174.
  • Asano N, Oseki K, Kizu H, et al. Nitrogen-in-the-ring pyranoses and furanoses: structural basis of inhibition of mammalian glycosidases. J Med Chem. 1994;37:3701–3706.
  • Muraoka O, Morikawa T, Miyake S, et al. Quantitative analysis of neosalacinol and neokotalanol, another two potent α-glucosidase inhibitors from Salacia species, by LC-MS with ion pair chromatography. J Nat Med. 2011;65:142–148.
  • Quezada-Calvillo R, Robayo-Torres CC, Ao Z, et al. Luminal substrate ‘brake’ on mucosal maltase-glucoamylase activity regulates total rate of starch digestion to glucose. J Pediatr Gastroenterol Nutr. 2007;45:32–43.
  • Sim L, Quezada-Calvillo R, Sterchi EE, et al. Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity. J Mol Biol. 2008;375:782–792.
  • Gao H, Kawabata J. 2-Aminoresorcinol is a potent α-glucosidase inhibitor. Bioorg Med Chem Lett. 2008;18:812–815.
  • Kato E, Tsuji H, Kawabata J. Selective purification of intestinal maltase complex by affinity chromatography employing an uncompetitive inhibitor as the ligand. Tetrahedron. 2015;71:1419–1424.
  • Lo Piparo E, Scheib H, Frei N, et al. Flavonoids for controlling starch digestion: structural requirements for inhibiting human α-amylase. J Med Chem. 2008;51:3555–3561.
  • Hara Y, Honda M. The inhibition of α-amylase by tea polyphenols. Agric Biol Chem. 1990;54:1939–1945.
  • Sales PM, Souza PM, Simeoni LA, et al. α-Amylase inhibitors: a review of raw material and isolated compounds from plant source. J Pharm Pharm Sci. 2012;15:141.
  • Svensson B, Fukuda K, Nielsen PK, et al. Proteinaceous α-amylase inhibitors. Biochim Biophys Acta - Proteins Proteomics. 2004;1696:145–156.
  • Yonemoto R, Shimada M, Gunawan-Puteri MDPT, et al. α-Amylase inhibitory triterpene from Abrus precatorius leaves. J Agric Food Chem. 2014;62:8411–8414.
  • Gunawan-Puteri MDPT, Kato E, Kawabata J. α-Amylase inhibitors from an Indonesian medicinal herb, Phyllanthus urinaria. J Sci Food Agric. 2012;92:606–609.
  • Ali H, Houghton PJ, Soumyanath A. α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol. 2006;107:449–455.
  • Li H, Tanaka T, Zhang Y-J, et al. Rubusuaviins A—F, monomeric and oligomeric ellagitannins from Chinese sweet tea and their α-amylase inhibitory activity. Chem Pharm Bull. 2007;55:1325–1331.
  • Robyt JF, French D. The action pattern of porcine pancreatic α-amylase in relationship to the substrate binding site of the enzyme. J Biol Chem. 1970;245:3917–3927.
  • Qian M, Haser R, Buisson G, et al. The active center of a mammalian alpha-amylase. Structure of the complex of a pancreatic alpha-amylase with a carbohydrate inhibitor refined to 2.2-A resolution. Biochemistry. 1994;33:6284–6294.
  • Svensson B. Regional distant sequence homology between amylases, α-glucosidases and transglucanosylases. FEBS Lett. 1988;230:72–76.
  • Kato E, Iwano N, Yamada A, et al. Synthesis and α-amylase inhibitory activity of glucose-deoxynojirimycin conjugates. Tetrahedron. 2011;67:7692–7702.
  • Kato E, Kushibiki N, Inagaki Y, et al. Astilbe thunbergii reduces postprandial hyperglycemia in a type 2 diabetes rat model via pancreatic alpha-amylase inhibition by highly condensed procyanidins. Biosci Biotechnol Biochem. 2017;81:1699–1705.
  • Kusano R, Ogawa S, Matsuo Y, et al. α-Amylase and lipase inhibitory activity and structural characterization of acacia bark proanthocyanidins. J Nat Prod. 2011;74:119–128.
  • Lee YA, Cho EJ, Tanaka T, et al. Inhibitory activities of proanthocyanidins from persimmon against oxidative stress and digestive enzymes related to diabetes. J Nutr Sci Vitaminol (Tokyo). 2007;53:287–292.
  • Wang H, Liu T, Song L, et al. Profiles and α-amylase inhibition activity of proanthocyanidins in unripe Manilkara zapota (Chiku). J Agric Food Chem. 2012;60:3098–3104.
  • Wang H, Song L, Feng S, et al. Characterization of proanthocyanidins in stems of polygonum multiflorum thunb as strong starch hydrolase inhibitors. Molecules. 2013;18:2255–2265.
  • Yanagida A, Kanda T, Tanabe M, et al. Inhibitory effects of apple polyphenols and related compounds on cariogenic factors of mutans streptococci. J Agric Food Chem. 2000;48:5666–5671.
  • Lavelli V, Sri Harsha PSC, Ferranti P, et al. Grape skin phenolics as inhibitors of mammalian α-glucosidase and α-amylase – effect of food matrix and processing on efficacy. Food Funct. 2016;7:1655–1663.
  • Kawakami K, Aketa S, Nakanami M, et al. Major water-soluble polyphenols, proanthocyanidins, in leaves of persimmon (Diospyros kaki) and their α-amylase inhibitory activity. Biosci Biotechnol Biochem. 2010;74:1380–1385.
  • Tsujita T, Shintani T, Sato H. α-amylase inhibitory activity from nut seed skin polyphenols. 1. Purification and characterization of almond seed skin polyphenols. J Agric Food Chem. 2013;61:4570–4576.
  • Nauck M. Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes Obes Metab. 2016;18:203–216.
  • Kato E, Uenishi Y, Inagaki Y, et al. Isolation of rugosin A, B and related compounds as dipeptidyl peptidase-IV inhibitors from rose bud extract powder. Biosci Biotechnol Biochem. 2016;80:2087–2092.
  • Kato E, Kawakami K, Kawabata J. Macrocarpal C isolated from Eucalyptus globulus inhibits dipeptidyl peptidase 4 in an aggregated form. J Enzyme Inhib Med Chem. 2018;33:106–109.
  • Lacroix IME, Li-Chan ECY. Food-derived dipeptidyl-peptidase IV inhibitors as a potential approach for glycemic regulation - Current knowledge and future research considerations. Trends Food Sci Technol. 2016;54:1–16.
  • Kozuka M, Yamane T, Nakano Y, et al. Identification and characterization of a dipeptidyl peptidase IV inhibitor from aronia juice. Biochem Biophys Res Commun. 2015;465:433–436.
  • Saleem S, Jafri L, Haq IU, et al. Plants Fagonia cretica L. and Hedera nepalensis K. Koch contain natural compounds with potent dipeptidyl peptidase-4 (DPP-4) inhibitory activity. J Ethnopharmacol. 2014;156:26–32.
  • Upadhyay J, Polyzos SA, Perakakis N, et al. Pharmacotherapy of type 2 diabetes: an update. Metabolism. 2018;78:13–42.
  • Ahmadian M, Suh JM, Hah N, et al. PPARγ signaling and metabolism: the good, the bad and the future. Nat Med. 2013;99:557–566.
  • Wang L, Waltenberger B, Pferschy-Wenzig E-M, et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol. 2014;92:73–89.
  • Hsu F-L, Liu I-M, Kuo D-H, et al. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod. 2003;66:788–792.
  • Kato E, Kawabata J. Glucose uptake enhancing activity of puerarin and the role of C-glucoside suggested from activity of related compounds. Bioorg Med Chem Lett. 2010;20:4333–4336.
  • Kato E, Inagaki Y, Kawabata J. Higenamine 4′-O-β-D-glucoside in the lotus plumule induces glucose uptake of L6 cells through β2-adrenergic receptor. Bioorg Med Chem. 2015;23:3317–3321.
  • Koshiyama H, Ohkuma H, Kawaguchi H, et al. Isolation of 1-(p-Hydroxybenzyl)-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline (demethylcoclaurine), an active alkaloid from Nelumbo nucifera. Chem Pharm Bull. 1970;18:2564–2568.
  • Kashiwada Y, Aoshima A, Ikeshiro Y, et al. Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure-activity correlations with related alkaloids. Bioorg Med Chem. 2005;13:443–448.
  • Kato E, Iwata R, Kawabata J. Synthesis and detailed examination of spectral properties of (S) and (R)-Higenamine 4ʹ-O-β-D-Glucoside and HPLC analytical conditions to distinguish the diastereomers. Molecules. 2017;22:1450.
  • Kato E, Kimura S, Kawabata J. Ability of higenamine and related compounds to enhance glucose uptake in L6 cells. Bioorg Med Chem. 2017;25:6412–6416.
  • Sato M, Dehvari N, Öberg AI, et al. Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle. Diabetes. 2014;63:4115–4129.
  • Mukaida S, Evans BA, Bengtsson T, et al. Adrenoceptors promote glucose uptake into adipocytes and muscle by an insulin-independent signaling pathway involving mechanistic target of rapamycin complex 2. Pharmacol Res. 2017;116:87–92.
  • Hong NY, Cui ZG, Kang HK, et al. P-Synephrine stimulates glucose consumption via AMPK in L6 skeletal muscle cells. Biochem Biophys Res Commun. 2012;418:720–724.
  • Jordan R, Midgley JM, Thonoor CM, et al. β-Adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig atria and trachea. J Pharm Pharmacol. 1987;39:752–754.
  • Haaz S, Fontaine KR, Cutter G, et al. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev. 2006;7:79–88.
  • Chikazawa M, Sato R. Identification of functional food factors as β2-Adrenergic receptor agonists and their potential roles in skeletal muscle. J Nutr Sci Vitaminol (Tokyo). 2018;64:68–74.
  • Lahrita L, Kato E, Kawabata J. Uncovering potential of Indonesian medicinal plants on glucose uptake enhancement and lipid suppression in 3T3-L1 adipocytes. J Ethnopharmacol. 2015;168:229–236.
  • Lahrita L, Hirosawa R, Kato E, et al. Isolation and lipolytic activity of eurycomanone and its epoxy derivative from Eurycoma longifolia. Bioorg Med Chem. 2017. DOI:10.1016/j.bmc.2017.07.032
  • Wang Q, Wang S, Yang X, et al. Myricetin suppresses differentiation of 3 T3-L1 preadipocytes and enhances lipolysis in adipocytes. Nutr Res. 2015;35:317–327.
  • Kang S, Shin H, Kim S. Sinensetin enhances adipogenesis and lipolysis by increasing cyclic adenosine monophosphate levels in 3T3-L1 adipocytes. Biol Pharm Bull. 2015;38:552–558.
  • Saito T, Abe D, Sekiya K. Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2007;357:371–376.
  • Gomez-Zorita S, Belles C, Briot A, et al. Pterostilbene inhibits lipogenic activity similar to resveratrol or caffeine but differently modulates lipolysis in adipocytes. Phyther Res. 2017;31:1273–1282.
  • Huh JY, Lee S, Ma E-B, et al. The effects of phenolic glycosides from Betula platyphylla var. japonica on adipocyte differentiation and mature adipocyte metabolism. J Enzyme Inhib Med Chem. 2018;33:1167–1173.
  • Watanabe A, Kato T, Ito Y, et al. Aculeatin, a coumarin derived from Toddalia asiatica (L.) Lam., enhances differentiation and lipolysis of 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2014;453:787–792.
  • Saravanan M, Pandikumar P, Saravanan S, et al. Lipolytic and antiadipogenic effects of (3,3-dimethylallyl) halfordinol on 3T3-L1 adipocytes and high fat and fructose diet induced obese C57/BL6J mice. Eur J Pharmacol. 2014;740:714–721.
  • Hsu H-F, Tsou T-C, Chao H-R, et al. Effects of arecoline on adipogenesis, lipolysis, and glucose uptake of adipocytes—A possible role of betel-quid chewing in metabolic syndrome. Toxicol Appl Pharmacol. 2010;245:370–377.
  • Frühbeck G, Méndez-Giménez L, Fernández-Formoso J-A, et al. Regulation of adipocyte lipolysis. Nutr Res Rev. 2014;27:63–93.
  • Souza SC, Palmer HJ, Kang Y-H, et al. TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. J Cell Biochem. 2003;89:1077–1086.
  • Bergan-Roller HE, Sheridan MA. The growth hormone signaling system: insights into coordinating the anabolic and catabolic actions of growth hormone. Gen Comp Endocrinol. 2018;258:119–133.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.